Elevance Health (ELV) Revenue — Quarter Ended Dec 31, 2024
Revenue increased in the reporting quarter. The growth rate moderated compared with the prior quarter, but was similar to the same quarter a year ago.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue increased in the reporting quarter. The growth rate moderated compared with the prior quarter, but was similar to the same quarter a year ago.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$45.4B
Revenue reported for this quarter.
Quarter-over-quarter
+0.7%
Change from the immediately preceding quarter.
Year-over-year
+6.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$177B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $42.6B | +1.0% |
| Jun 30, 2024 | $43.9B | +0.5% |
| Sep 30, 2024 | $45.1B | +5.3% |
| Dec 31, 2024 | $45.4B | +6.6% |
Revenue performance
Revenue improved from the preceding quarter, continuing the upward trend seen throughout the fiscal year. The year-over-year increase was comparable to the prior quarter's pace.
Quarterly comparison
Relative to the immediately preceding quarter, revenue rose further, though at a slower rate. When measured against the same quarter one year earlier, the revenue level was higher by a mid-single-digit percentage.
What to watch
Filing context lists risk factors and management discussion but provides no specific operational details for this quarter.